The thoracic catheters market is expanding as healthcare providers manage a growing burden of respiratory and thoracic conditions while increasingly adopting minimally invasive surgical techniques. The market was valued at USD 484.4 million in 2025 and is estimated to reach USD 508.3 million in 2026. It is projected to grow to USD 748.9 million by 2033, registering a CAGR of 5.7% from 2026 to 2033.

Download a free sample copy of the Thoracic Catheters market report to understand detailed coverage and inclusions in the final report

Market Overview & Growth Drivers

The rising prevalence of respiratory and thoracic conditions is one of the primary factors supporting market expansion. Pleural effusion, pneumothorax, lung cancer, chronic obstructive pulmonary disease, and postoperative complications can require thoracic drainage and respiratory support. Growing smoking rates, air pollution, and lifestyle-related lung disorders are further contributing to the need for thoracic interventions.

The increasing number of thoracic and pulmonary surgeries is another important growth factor. Minimally invasive procedures, including video-assisted thoracoscopic surgery and robotic-assisted thoracic surgeries, are becoming more prevalent because they can reduce trauma, shorten recovery periods, and support shorter hospital stays. These procedures create demand for catheter systems that can provide effective drainage through smaller incisions while minimizing patient discomfort.

Technological innovation is also changing the product landscape. Small-bore and soft-tipped catheters, antimicrobial coatings, biocompatible materials, image-guided placement, and ultrasound-assisted techniques are improving safety, procedural precision, and patient comfort. Digital monitoring systems, one-way valves, and portable collection devices are additionally supporting more precise fluid management and expanding opportunities for outpatient and home-based care.

The market is characterized by moderate technological advancement and growing demand from established healthcare settings. Manufacturers are increasingly developing patient-centric products featuring antimicrobial coatings, kink-resistant designs, and improved drainage efficiency. Regulatory frameworks and product-quality requirements are also encouraging investment in advanced catheter designs and materials.

Market Segmentation & Regions

By product, pleural drainage catheters accounted for the largest market revenue share in 2025. Their widespread use in treating pleural effusion, pneumothorax, and other thoracic conditions makes them an important part of hospital, emergency-care, and postoperative procedures. The thoracostomy tubes segment is expected to register the fastest CAGR during the forecast period, supported by demand in emergency and postsurgical management of pneumothorax, hemothorax, and pleural effusion.

Silicone accounted for the largest market revenue share by material in 2025. Its biocompatibility, flexibility, durability, and non-reactive characteristics make it suitable for thoracic applications. Polyurethane is expected to grow at the fastest CAGR during the forecast period because of its combination of strength, flexibility, biocompatibility, kink resistance, and suitability for thin-walled catheter designs.

Pneumothorax accounted for the largest application revenue share in 2025 and is also projected to grow at the fastest CAGR during the forecast period. Thoracic catheters are essential for removing trapped air from the pleural cavity and restoring lung expansion. Pleural effusion represents another important application, with demand supported by chronic respiratory diseases, congestive heart failure, malignancies, infections, and an aging population.

Hospitals led the end-use segment with a 54.5% revenue share in 2025. High volumes of thoracic procedures, emergency interventions, trauma cases, intensive-care requirements, and postoperative drainage contribute to their dominant position. Ambulatory surgical centers are expected to register the fastest CAGR as healthcare systems increasingly shift toward outpatient and minimally invasive procedures.

North America dominated the market with a 42.5% revenue share in 2025, supported by respiratory disease prevalence, thoracic surgery volumes, advanced healthcare infrastructure, minimally invasive and robotic-assisted procedures, and continuous product innovation. The U.S. held the largest market share in the region in 2025.

Asia Pacific is expected to register the fastest CAGR during the forecast period. Rising healthcare investment, improving hospital infrastructure, increasing respiratory disease prevalence, and greater adoption of minimally invasive and image-guided procedures are supporting expansion. India is experiencing significant growth as respiratory diseases such as tuberculosis, COPD, and lung infections, together with increasing thoracic surgeries and expanding multispecialty hospital networks, strengthen demand.

With the market projected to rise from USD 508.3 million in 2026 to USD 748.9 million by 2033, continued demand for minimally invasive thoracic care, advanced materials, infection-control features, portable drainage systems, and improved procedural accuracy is expected to support the industry's development.

FAQs

How big is the thoracic catheters market?

The thoracic catheters market was valued at USD 484.4 million in 2025, is estimated at USD 508.3 million in 2026, and is projected to reach USD 748.9 million by 2033, at a CAGR of 5.7% from 2026 to 2033.

Which segment leads the thoracic catheters market?

Pleural drainage catheters led the product segment in 2025, silicone led by material, pneumothorax led by application, and hospitals led the end-use segment with a 54.5% revenue share in 2025

Key Thoracic Catheters Companies:

·        Teleflex Incorporated

·        Smiths Medical (ICU Medical, Inc.)

·        B. Braun Melsungen AG

·        Vygon SA

Explore the full list of profiled companies operating in this market with recent strategic initiatives

About us:
Grand View Research, a market research and consulting company, provides syndicated research reports, customized research reports, and consulting services. Grand View Research database is used by the world's renowned academic institutions and Fortune 500 companies to understand the global and regional business environment. Our database features thousands of statistics and in-depth analysis on 46 industries in 25 major countries worldwide.